The remaining two patients were two sisters (one with clear cell carcinoma and the other with serous carcinoma) who carried the BRCA2 VUS p.S1946P (predicted to be pathogenic by Grantham but classified as benign by SIFT and PolyPhen). The gene discussed is BRCA2; the disease is serous adenocarcinoma.